SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ivan Andrew who wrote (55)9/5/1996 8:39:00 PM
From: Julio P. Antelo   of 61
 
All's quiet on the Western front.

Still following the company and still invested, but since there have been no news from the company in recent weeks there has been no need to post. Last quarter ended July 31, so a sales/earnings report should be out very soon reporting on the combined ZILA/BDTC entity. I'm guessing maybe $42 million for the entire year, but this report is really a non-event. Sadly, there has been no developments on the FDA approval process. Back in June the company had indicated that it may be October before they knew anything; it sure looks that way to me.

By the way, you did catch the news that ZILA is now a marginable stock? I hope it makes it to the National Market soon; I'm tired of looking at that tiny print in IBD. Regards, Julio.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext